Casabianca, A <br/><br/>
Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.  [electronic resource] 

 -  Infection  Aug 2011 
 - 375-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-0973 
<br/><br/><label>Standard No.: </label>10.1007/s15010-011-0109-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amphotericin B--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antiprotozoal Agents--therapeutic use<br/>Bone Marrow--parasitology<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Immunocompromised Host<br/>Italy<br/>Leishmania infantum--drug effects<br/>Leishmaniasis, Visceral--blood<br/>Leukocytes, Mononuclear--parasitology<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Polymerase Chain Reaction<br/>Polymorphism, Restriction Fragment Length<br/>Recurrence<br/>Rituximab